US Regeneron, a Biotechnology Company, to Acquire Bankrupt DNA Testing Firm 23andMe for $256 Million Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months… NewsFinale JournalMay 19, 2025 View Post